Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for ITP and 80,000+ other tickers.
See exactly how ITP's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for ITP and 80,000+ other tickers.
IT Tech Packaging, Inc. operates within the People's Republic of China, focusing on the manufacturing and distribution of a diverse array of paper and related products. The company supplies corrugating medium papers, which are utilized by businesses in the production of corrugated cardboard, and also provides offset printing papers to printing establishments. Under its "Dongfang Paper" brand, IT Tech Packaging offers an extensive selection of tissue products, encompassing toilet paper, various boxed and soft-packed facial tissues, handkerchiefs, paper napkins, and both bathroom and kitchen…
Sanofi's Wayrilz approved in Japan to treat immune thrombocytopenia Wayrilz is a BTK inhibitor that works through multi-immune modulation to help address the underlying causes of immune thrombocytopenia (ITP) Approval based on the LUNA 3 phase 3 study that demonstrated rapid and durable platelet response and improvements in other symptoms ITP is a rare disease of complex immune dysregulation leading to lower platelet counts, bleeding, and reduced quality of life Paris, June 23, 2026. The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization to Wayrilz (rilzabrutinib), a novel oral reversible Bruton's tyrosine kinase inhibitor (BTKi), for the treatment of persistent or chronic immune thrombocytopenia (ITP) in patients who do not respond sufficiently to other treatments or in whom tolerability is considered to be problematic.
Data demonstrate favorable safety and tolerability profile, robust B-cell depletion, and encouraging platelet responses in heavily pretreated patients with primary immune thrombocytopenia Enrollment ongoing in the high dose cohort, with additional data anticipated by year-end 2026 WELLESLEY HILLS, Mass., June 11, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced initial data from the ongoing Phase 1b portion of its Phase 1b/2a study evaluating budoprutug, an anti-CD19 monoclonal antibody, in adults with primary immune thrombocytopenia (ITP) demonstrating an encouraging safety and tolerability profile, robust B-cell depletion, and meaningful platelet responses in heavily pretreated patients.
BAODING, China, April 20, 2026 /PRNewswire/ -- IT Tech Packaging Inc. (NYSE American: ITP) ("IT Tech Packaging" or the "Company"), a leading manufacturer and distributor of diversified paper products in North China, received an official notice of noncompliance (the "NYSE American Notice") from NYSE Regulation ("NYSE") stating that the Company is not in compliance with NYSE American continued listing standards (the "Filing Delinquency Notification") due to the failure to timely file the Company's Form 10-K for the year ended December 31, 2025 (the "Delinquent Report") by the filing due date of April 15, 2026 (the "Filing Delinquency"). The Company is now subject to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide (the "Company Guide").
Shares of IT Tech Packaging, Inc. (NYSE: ITP - Get Free Report) traded up 5% during trading on Tuesday. The company traded as high as $0.2450 and last traded at $0.2430. 192,689 shares traded hands during trading, a decline of 95% from the average session volume of 3,803,764 shares. The stock had previously closed at
BAODING, China , Oct. 31, 2025 /PRNewswire/ -- IT Tech Packaging, Inc. (NYSE American: ITP) ("IT Tech Packaging" or the "Company"), a leading manufacturer and distributor of diversified paper products in North China, today announced the results of the Company's 2025 Annual General Meeting of Stockholders (the "Annual Meeting") held at the Company's production base in Wei County, Hebei Province, China. at 10:00 a.m.